Holen Sie sich die Stockscreener-App
7.42
1.16%
0.085
Handel nachbörslich:
7.42
Schlusskurs vom Vortag:
$7.335
Offen:
$7.36
24-Stunden-Volumen:
407.83K
Relative Volume:
0.83
Marktkapitalisierung:
$451.49M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-4.9467
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+4.80%
1M Leistung:
-6.55%
6M Leistung:
+20.06%
1J Leistung:
-19.00%
1-Tages-Spanne:
$7.18
$7.52
1-Wochen-Bereich:
$6.72
$7.52
52-Wochen-Spanne:
$5.42
$11.41
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
7.42 | 451.49M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
213.03 | 34.59B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
67.12 | 11.60B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.22 | 10.31B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
97.47 | 8.45B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Insider Sell: Duncan Gallagher Sells 4,500 Shares of Health Cata - GuruFocus.com
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Director Sells 4,500 Shares of Stock - MarketBeat
Health Catalyst director Gallagher Duncan sells $31,184 in stock By Investing.com - Investing.com Australia
Health Catalyst director Gallagher Duncan sells $31,184 in stock - Investing.com
Health Catalyst, Inc. (NASDAQ:HCAT) Director Duncan Gallagher Sells 4,500 Shares - MarketBeat
Health Catalyst director Gallagher Duncan sells $31,415 in stock By Investing.com - Investing.com Australia
Health Catalyst director Gallagher Duncan sells $31,415 in stock - Investing.com India
Shareholders in Health Catalyst (NASDAQ:HCAT) are in the red if they invested three years ago - Yahoo Finance
How to Take Advantage of moves in (HCAT) - Stock Traders Daily
Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail
Health Catalyst (HCAT): Buy, Sell, Or Hold Post Q3 Earnings? - Barchart
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Health Catalyst Inc (HCAT-Q) QuotePress Release - The Globe and Mail
Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Target Price at $11.79 - MarketBeat
Health Catalyst (NASDAQ:HCAT shareholders incur further losses as stock declines 13% this week, taking three-year losses to 81% - Simply Wall St
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 6,442 Shares of Stock - MarketBeat
Insider Sell: Linda Llewelyn Sells Shares of Health Catalyst Inc (HCAT) - GuruFocus.com
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating (NASDAQ:HCAT) - Seeking Alpha
Healthcare Analytics Market Size, Trends, Growth, - openPR
Health Catalyst leaders share 2025 predictions - Modern Healthcare
Health Catalyst's SWOT analysis: stock outlook amid healthcare IT evolution By Investing.com - Investing.com South Africa
Health Catalyst's SWOT analysis: stock outlook amid healthcare IT evolution - Investing.com
Health Catalyst CFO Jason Alger sells shares worth $163,049 By Investing.com - Investing.com South Africa
Health Catalyst To Participate In Upcoming Investor Conference - Barchart
Health Catalyst CFO Jason Alger sells shares worth $163,049 - Investing.com India
Health Catalyst general counsel Landry Benjamin sells $160,294 in stock By Investing.com - Investing.com Nigeria
Health Catalyst general counsel Landry Benjamin sells $160,294 in stock - Investing.com
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst to Present at J.P. Morgan's 43rd Annual Healthcare Conference - StockTitan
Point72 Asset Management L.P. Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Jacobs Levy Equity Management Inc. Has $913,000 Position in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare - Kilgore News Herald
Health Catalyst COO Daniel LeSueur sells shares worth $175,242 By Investing.com - Investing.com Australia
Health Catalyst COO Daniel LeSueur sells shares worth $175,242 - Investing.com India
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health - Healthcare IT Today
(HCAT) Proactive Strategies - Stock Traders Daily
Health Catalyst chief commercial officer sells $67,073 in stock By Investing.com - Investing.com Canada
Fred Alger Management LLC Makes New $6.86 Million Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Has $1.07 Million Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Millrace Asset Group Inc. Buys New Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Piper Sandler - MarketBeat
Piper Sandler raises Health Catalyst target to $12 on growth outlook - Investing.com Nigeria
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.26%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):